<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="336100">
  <stage>Registered</stage>
  <submitdate>15/10/2010</submitdate>
  <approvaldate>19/10/2010</approvaldate>
  <actrnumber>ACTRN12610000886088</actrnumber>
  <trial_identification>
    <studytitle>Pressure limit selection during neonatal assist control volume guarantee ventilation: A randomised crossover trial</studytitle>
    <scientifictitle>Pressure limit selection during neonatal assist control volume guarantee ventilation: A randomised crossover trial</scientifictitle>
    <utrn />
    <trialacronym>AC/VG Pmax Study</trialacronym>
    <secondaryid>None</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Neonatal ventilation</healthcondition>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Other respiratory disorders / diseases</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Complications of newborn</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Ventilator pressure limit settings will be compared in random order. The intervention periods (epochs) will last for 20 mins. Each epoch will be preceded by a 10 minute washout period. Infants will be ventilated using assist control volume guarantee mode with the Drager Babylog 8000plus ventilator throughout the study.

The following selection methods will be compared:
[A] The current standard setting in the neonatal intensive care unit (30 cm H2O)
[B] A setting based upon the average delivered PIP for triggered inflations (identified by the researcher) + 5 cm H2O
[C] A setting based upon the perceived 'working PIP' (as reported by the staff caring for the baby) + 5 cm H2O</interventions>
    <comparator>See description of interventions</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Proportion of ventilator inflations with expired tidal volume with 90-110% of target tidal volume, identified from the ventilator waveforms/trigger data</outcome>
      <timepoint>These data are measured continually. The outcome is defined as the number of inflations in range / total number of inflations over the epoch</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Ventilator parameters determined from the ventilator data including:
Rate, mean airway pressure, peak inflating pressure</outcome>
      <timepoint>The data are measure continually over the epoch. Epoch averages will be compared</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Measures of cardiorespiratory stability including:
FiO2, SpO2, TcCO2, HR and BP assessed using the ventilator data, Masimo Radical pulse oximeter, and Philips Intellivue series monitor with transcutaneous module</outcome>
      <timepoint>These data are recorded every minute. The change over the epoch will be measured (average data from last 2 mins of epoch minus average data from last 2 mins of run in period prior to epoch)</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Stable ventilated infants, ventilated using assist control volume guarantee (AC/VG) for previous 24 hours.</inclusivecriteria>
    <inclusiveminage>24</inclusiveminage>
    <inclusiveminagetype>Hours</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Ventilator changes in previous 4 hours, pH &lt; 7.2, pCO2&gt;80 mmHg, FiO2 &gt; 0.8, acute pneumothoax/pulmonary interstitial emphysema, significant congenital abnormality, severe PVH, receiving muscle relaxants or morphine infusion &gt; 20 ug/kg/hr</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Randomised crossover trial. Allocation of order of interventions using sequentially numbered opaque envelopes</concealment>
    <sequence>Computer generated random number sequence</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Crossover</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>29/10/2008</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>26</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Royal Women's Hospital</primarysponsorname>
    <primarysponsoraddress>Locked Bag 300
Cnr Grattan Street/Flemington Road
Parkville
Vic 3052</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>NMHRC</fundingname>
      <fundingaddress>National Health and Medical Research Council
GPO Box 1421
Canberra ACT 2601</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The purpose of this project is to study how ventilators (breathing machines) support babies. We are investigating how we use the ventilator with the aim of better matching the babies' natural breathing patterns. 

The ventilator can vary the pressure it uses to adjust to your babys breathing. We set a maximum inflation pressure limit for how high it can go. Previous experience suggests that this having this limit set higher means babies can get a mixture of higher and lower pressures which may irritate some babies. Setting the limit lower means the ventilation pressures are more even. If the ventilator senses that the pressure limit is too low it will sound an alarm.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>The Royal Womens Hospital Research and Ethics Committees</ethicname>
      <ethicaddress>Locked Bag 300
Cnr Grattan St/Flemington Road
Parkville
Vic 3052</ethicaddress>
      <ethicapprovaldate>10/01/2008</ethicapprovaldate>
      <hrec>Project 07/33</hrec>
      <ethicsubmitdate>29/11/2007</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Kevin Wheeler</name>
      <address>Newborn Research
Royal Women's Hospital
Locked Bag 300
Cnr Grattan Street/Flemington Road
Parkville
Vic 3052</address>
      <phone>+61 3 8345 2000</phone>
      <fax />
      <email>kevin.wheeler@thewomens.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Kevin Wheeler</name>
      <address>Newborn Research
Royal Women's Hospital
Locked Bag 300
Cnr Grattan Street/Flemington Road
Parkville
Vic 3052</address>
      <phone>+61 3 8345 2000</phone>
      <fax />
      <email>kevin.wheeler@thewomens.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>